Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 5,860 ALGS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 5,860 | n/a |
| Jun 26, 2025 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 5,860 | n/a |
| Jun 6, 2025 | IO Biotech, Inc. (IOBT) | Grant/Award | 35,144 | n/a |
| Jun 28, 2024 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 60,000 | n/a |
| Jun 10, 2024 | Vaxcyte, Inc. (PCVX) | Grant/Award | 1,550 | n/a |
| Jun 7, 2024 | IO Biotech, Inc. (IOBT) | Grant/Award | 45,642 | n/a |
| Feb 28, 2024 | Aligos Therapeutics, Inc. (ALGS) | Disposition to Issuer | 15,000 | n/a |
| Jul 21, 2023 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 20,000 | n/a |
| Jun 15, 2023 | Vaxcyte, Inc. (PCVX) | Grant/Award | 2,500 | n/a |
| Jun 13, 2023 | IO Biotech, Inc. (IOBT) | Grant/Award | 41,533 | n/a |